2022-500801-41-00招募中1 期
A trial to test if different amounts of KTX-1001 are safe and tolerable in people with the bone marrow cancer multiple myeloma that has come back or where treatment did not work.
K36 Therapeutics Inc.8 个研究点 分布在 2 个国家目标入组 24 人开始时间: 2023年3月6日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 24
- 试验地点
- 8
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Sanjana Miskin
Scientific
K36 Therapeutics Inc.
研究点 (8)
Loading locations...
相似试验
已完成
不适用
The efficacy test of KTT002Healthy adultsJPRN-UMIN000031053Kao Corporation345
招募中
2 期
Procedural sedation and analgesia of reduction of shoulder dislocation.Dislocation of shoulder joint.Subluxation and dislocation of shoulder jointIRCT20180627040258N1Artesh University of Medical Sciences150
已完成
不适用
To test the number of Circulating Tumor Cells (CTC) captured by the OncoDiscover Liquid Biopsy in peripheral blood samples of Head and Neck cancer patients.CTRI/2018/03/012905Actorius Innovations and Research Pvt Ltd100
进行中（未招募）
不适用
A study to test whether different combinations of BI 765063, ezabenlimab, chemotherapy, cetuximab, and BI 836880 help people with head and neck cancer or liver cancerPatients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) or hepatocellular cjRCT2031210650Nippon Boehringer Ingelheim Co., Ltd.150
已完成
不适用
Increasing organ donation via anticipated regret: the INORDAR projectRegretMental and Behavioural DisordersISRCTN92204897niversity of Stirling (UK)2,260